Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

USMJ Relaunches EVERx CBD Sports Nutrition Beverage - New Look And New Formula

Dallas, Texas, Feb. 17, 2022 (GLOBE NEWSWIRE) -- North American Cannabis Holdings, Inc. (OTC Pink: USMJ) today announced the official relaunch of the EVERx CBD Sports Nutrition Beverage. USMJ acquired EVERx from its sister company, Puration, Inc. (OTC Pink: PURA) last year. 

After developing EVERx as part of an overall cannabis infused consumable business development and exploration initiative, PURA subsequently retooled its business to focus on the overall potential of the industrial hemp market.  PURA sold EVERx to USMJ in exchange for a perpetual royalty agreement.

PURA established EVERx as the leading CBD beverage in the sports nutrition market with millions in annual sales.  USMJ’s ecommerce site, www.USMJ.com, served as one distribution channel for EVERx.

Acquiring EVERx mid pandemic, USMJ decided to wait out the economic impact of the pandemic and target a later relaunch of the CBD sports nutrition beverage.

USMJ is now relaunching the product with an updated formula and look. The new formula and look are designed to expand the appeal of EVERx beyond the sports nutrition market. Alkame Holdings, Inc. (OTC Pink: ALKM) remains as the bottler for EVERx.

To learn more about the new formula and to see the new packaging visit:  www.DRINKEVERx.com

USMJ plans to make a major trade show announcement before the end of the month in conjunction with the relaunch of EVERx.  USMJ will reintroduce the EVERx CBD Sports Nutrition Beverage live at an upcoming major trade show.

The relaunch of EVERx is the beginning of an overall USMJ cannabis ecommerce expansion campaign.  Following the relaunch of EVERx, USMJ has plans to launch multiple new products, both inhouse products and third-party products, in an overall effort to expand USMJ ecommerce sales.

In September of last year, ACI Conglomerated, the controlling shareholder of USMJ and the controlling shareholder of Puration, Inc. (OTC Pink: PURA) and Priority Aviation, Inc. (OTC Pink: PJET), announced its plans to refocus and diversify its overall strategy with the three companies.

PJET diversified outside the cannabis industry, entering the student life market.

PURA refocused its business on industrial hemp. 

USMJ, after exiting the cannabis retail restaurant market, is now focused on expanding its cannabis ecommerce footprint. 

Visit the company’s ecommerce site now and bookmark the site to watch for more coming announcements and updates:

www.USMJ.com

Contact:
USMJ
Steven Rash
[email protected]
+1 (800) 861-1350

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Attachment


Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).